123 related articles for article (PubMed ID: 28063109)
21. Inherited forms of renal cell carcinoma.
Kiuru M; Kujala M; Aittomäki K
Scand J Surg; 2004; 93(2):103-11. PubMed ID: 15285561
[TBL] [Abstract][Full Text] [Related]
22. Novel somatic mutations in the VHL gene in Swedish archived sporadic renal cell carcinomas.
Yang K; Lindblad P; Egevad L; Hemminki K
Cancer Lett; 1999 Jul; 141(1-2):1-8. PubMed ID: 10454237
[TBL] [Abstract][Full Text] [Related]
23. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
[TBL] [Abstract][Full Text] [Related]
24. JAK3 in clear cell renal cell carcinoma: mutational screening and clinical implications.
de Martino M; Gigante M; Cormio L; Prattichizzo C; Cavalcanti E; Gigante M; Ariano V; Netti GS; Montemurno E; Mancini V; Battaglia M; Gesualdo L; Carrieri G; Ranieri E
Urol Oncol; 2013 Aug; 31(6):930-7. PubMed ID: 21868263
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of COPS3 promotes clear cell renal cell carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3.
Hong Y; Huang X; An L; Ye H; Ma K; Zhang F; Xu Q
Exp Cell Res; 2018 Apr; 365(2):163-170. PubMed ID: 29477618
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
Morris MR; Hughes DJ; Tian YM; Ricketts CJ; Lau KW; Gentle D; Shuib S; Serrano-Fernandez P; Lubinski J; Wiesener MS; Pugh CW; Latif F; Ratcliffe PJ; Maher ER
Anticancer Res; 2009 Nov; 29(11):4337-43. PubMed ID: 20032376
[TBL] [Abstract][Full Text] [Related]
27. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases.
Ulamec M; Skenderi F; Zhou M; Krušlin B; Martínek P; Grossmann P; Peckova K; Alvarado-Cabrero I; Kalusova K; Kokoskova B; Rotterova P; Hora M; Daum O; Dubova M; Bauleth K; Slouka D; Sperga M; Davidson W; Rychly B; Perez Montiel D; Michal M; Hes O
Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):521-30. PubMed ID: 26447894
[TBL] [Abstract][Full Text] [Related]
28. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma.
Togo Y; Yoshikawa Y; Suzuki T; Nakano Y; Kanematsu A; Zozumi M; Nojima M; Hirota S; Yamamoto S; Hashimoto-Tamaoki T
Int J Oncol; 2016 Apr; 48(4):1571-80. PubMed ID: 26891804
[TBL] [Abstract][Full Text] [Related]
29. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
Bugert P; Wilhelm M; Kovacs G
Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
[TBL] [Abstract][Full Text] [Related]
30. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU
Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868
[TBL] [Abstract][Full Text] [Related]
31. Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.
Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Matin SF; Karam JA; Huang M; Chang DW; Wood CG; Wu X
Clin Cancer Res; 2016 Apr; 22(8):2074-82. PubMed ID: 26655847
[TBL] [Abstract][Full Text] [Related]
32. Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature.
Peckova K; Vanecek T; Martinek P; Spagnolo D; Kuroda N; Brunelli M; Vranic S; Djuricic S; Rotterova P; Daum O; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Dubova M; Kalusova K; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2014 Dec; 18(6):351-7. PubMed ID: 25438924
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
34. Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma.
Antwi SO; Eckel-Passow JE; Diehl ND; Serie DJ; Custer KM; Wu KJ; Cheville JC; Thiel DD; Leibovich BC; Parker AS
Int J Cancer; 2018 Feb; 142(4):747-756. PubMed ID: 29023769
[TBL] [Abstract][Full Text] [Related]
35. Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.
Marsaud A; Dadone B; Ambrosetti D; Baudoin C; Chamorey E; Rouleau E; Lefol C; Roussel JF; Fabas T; Cristofari G; Carpentier X; Michiels JF; Amiel J; Pedeutour F
Genes Chromosomes Cancer; 2015 Jun; 54(6):369-82. PubMed ID: 25820192
[TBL] [Abstract][Full Text] [Related]
36. Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine.
Myszka A; Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
Fam Cancer; 2018 Jul; 17(3):345-349. PubMed ID: 29052111
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms of DNA repair genes are associated with renal cell carcinoma.
Hirata H; Hinoda Y; Matsuyama H; Tanaka Y; Okayama N; Suehiro Y; Zhao H; Urakami S; Kawamoto K; Kawakami T; Igawa M; Naito K; Dahiya R
Biochem Biophys Res Commun; 2006 Apr; 342(4):1058-62. PubMed ID: 16510122
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA expression profiling of Xp11 renal cell carcinoma.
Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations in renal cell carcinoma with rhabdoid differentiation.
Perrino CM; Hucthagowder V; Evenson M; Kulkarni S; Humphrey PA
Hum Pathol; 2015 Jan; 46(1):9-16. PubMed ID: 25439741
[TBL] [Abstract][Full Text] [Related]
40. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
